avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spib
|
ENSMUSG00000008193.7 | Spi-B transcription factor (Spi-1/PU.1 related) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spib | mm10_v2_chr7_-_44532064_44532078 | 0.81 | 2.3e-09 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.1 | GO:0030221 | basophil differentiation(GO:0030221) |
6.6 | 19.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
4.6 | 27.5 | GO:0032796 | uropod organization(GO:0032796) |
4.4 | 13.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.1 | 12.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.5 | 17.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
3.3 | 9.8 | GO:0042231 | interleukin-10 biosynthetic process(GO:0042091) interleukin-13 biosynthetic process(GO:0042231) regulation of interleukin-10 biosynthetic process(GO:0045074) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
3.2 | 32.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.2 | 12.8 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
3.0 | 8.9 | GO:2000458 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
2.9 | 11.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.8 | 14.2 | GO:0070560 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) protein secretion by platelet(GO:0070560) |
2.8 | 17.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
2.7 | 10.9 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.7 | 8.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
2.6 | 7.7 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.5 | 7.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
2.5 | 17.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.2 | 8.8 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
2.0 | 10.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.0 | 6.0 | GO:2000040 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
2.0 | 15.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.9 | 11.7 | GO:0032439 | endosome localization(GO:0032439) negative regulation of vacuolar transport(GO:1903336) |
1.8 | 5.5 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
1.7 | 6.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 4.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.6 | 6.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.5 | 9.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.5 | 4.4 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.5 | 5.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.4 | 5.5 | GO:0033373 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
1.4 | 4.1 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.3 | 6.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.2 | 3.5 | GO:0051659 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
1.2 | 3.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.1 | 3.4 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
1.1 | 3.4 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.1 | 5.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.1 | 8.9 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.1 | 6.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 14.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.0 | 11.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.0 | 3.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.9 | 8.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 5.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.9 | 6.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.8 | 4.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.8 | 4.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 4.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 2.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.8 | 6.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.7 | 6.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 3.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 2.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 4.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 2.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 3.8 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 2.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 6.9 | GO:0035878 | nail development(GO:0035878) |
0.6 | 4.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 2.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 1.7 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.6 | 4.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.5 | 5.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 4.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 18.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.5 | 3.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.5 | 25.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 5.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.4 | 4.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.4 | 2.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 1.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.3 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 14.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.3 | 1.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.9 | GO:2000793 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) cell proliferation involved in heart valve development(GO:2000793) |
0.3 | 7.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 5.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.6 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 2.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 5.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.7 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.2 | 1.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 2.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 2.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 6.9 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 4.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 3.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 13.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 4.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.8 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 3.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 2.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 2.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 2.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 3.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 7.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 3.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.8 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.5 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 3.7 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 3.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.9 | GO:0086023 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 5.3 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 6.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 5.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 2.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 3.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 2.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 3.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 1.5 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.2 | GO:1901301 | pulmonary artery morphogenesis(GO:0061156) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 7.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 6.3 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.0 | 4.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 14.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 5.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 7.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 7.1 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.1 | GO:0014735 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) regulation of muscle atrophy(GO:0014735) |
0.0 | 4.8 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 1.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 2.0 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 3.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.3 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 20.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.4 | 14.5 | GO:0032437 | cuticular plate(GO:0032437) |
2.0 | 5.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.9 | 11.7 | GO:0097443 | sorting endosome(GO:0097443) |
1.5 | 12.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.5 | 24.3 | GO:0042581 | specific granule(GO:0042581) |
1.2 | 27.5 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 12.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.9 | 2.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.9 | 3.4 | GO:0036019 | endolysosome(GO:0036019) |
0.9 | 7.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.8 | 13.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.7 | 6.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 9.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 6.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 4.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.6 | 3.5 | GO:0031673 | H zone(GO:0031673) |
0.5 | 5.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 5.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 9.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 5.5 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 27.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 8.9 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 5.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 7.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 4.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.3 | 9.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 3.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 24.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 11.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 5.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 2.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 3.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 6.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 17.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 5.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 9.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 4.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 19.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 2.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 4.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 9.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 4.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 5.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 31.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 10.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 9.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 3.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 6.3 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 6.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 11.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 3.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 15.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 1.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 3.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.6 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
3.8 | 11.4 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
3.0 | 9.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
3.0 | 8.9 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
2.0 | 15.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.8 | 11.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.7 | 7.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.6 | 17.5 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.5 | 8.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.4 | 23.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.4 | 4.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.4 | 12.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.3 | 18.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.2 | 27.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.2 | 3.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
1.1 | 8.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 6.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.8 | 2.3 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.7 | 4.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 6.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 7.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.6 | 20.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 19.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 2.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.5 | 3.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.5 | 21.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 3.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 14.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 3.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 14.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 3.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 18.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 7.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.3 | 4.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 4.9 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 4.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 3.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 3.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.7 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.3 | 4.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 12.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 5.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 21.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 2.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 17.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 4.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 5.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 4.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 5.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 4.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 3.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 37.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 2.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 18.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 2.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 4.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 4.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 4.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 32.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 7.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 3.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 5.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 6.6 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 1.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 4.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 1.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 2.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 6.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 2.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 4.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 4.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 3.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 2.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 3.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 3.9 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 1.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 6.7 | GO:0005509 | calcium ion binding(GO:0005509) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 39.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 8.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 14.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 30.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 34.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 21.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 24.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 11.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 21.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 5.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 9.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 13.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 7.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 8.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 9.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 4.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 7.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 5.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 9.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 5.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 5.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 6.4 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 8.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.0 | 12.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 14.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 3.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.7 | 3.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 30.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 24.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 4.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 7.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 5.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 6.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 6.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 9.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 4.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 7.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 14.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 15.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 5.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 3.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 18.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 51.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 20.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 18.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 6.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 7.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 17.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 6.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 17.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 7.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 7.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 9.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 16.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 5.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 6.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 4.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 2.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 7.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 2.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |